MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202641088638 A) filed by Dr. S Ramya on July 21, 2026, for Boerhavia Diffusa Nanoformulation To Evalute Caffine Toxicity In Zebrafish Embryos.
Inventors include Dr. S Ramya; Arun Giri T; Dhanusri M; Hariharen V; and Subiksha Manikandan.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: ABSTRACT The increasing need for safe and effective plant-based nutraceuticals has encouraged the applir.atinn of nanntitchnnlogy to hnnst the therapeutic potential of medicinal plants. Boerhavia diffusa, a well-known medicinal herb with antioxidant, anti-inflammatory, and hepatoprotective characteristics, possesses great therapeutic efficacy. However, its poor solubility and restricted absorption impede its therapeutic usefulness. This study intends to construct a nanoformulation of Boerhavia diffirsa to overcome these constraints and increase its functional performance. The plant extract will be nanoencapsulated to enhance the stability, solubility, and controlled release of its bioactive chemicals. The created nanoparticles will be assessed based on particle size, zeta potential, encapsulation efficiency, and stability to ensure the development of an optimal and dependable nanoformulation with better physicochemical attributes. The increasing need for safe and effective plant-based nutraceuticals has encouraged the application of nanotechnology to boost the therapeutic potential of medicinal plants. Boerhavia dffilsa, a well-known medicinal herb with antioxidant, anti-inflammatory, and hepatoprotective characteristics, possesses great therapeutic efficacy. However, its poor solubility and restricted absorption impede its therapeutic usefulness. This study intends to construct a nanoformulation of Boerhavia diffusa to overcome these constraints and increase its functional performance. The plant extract will be nanoencapsulated to enhance the stability, solubility, and controlled release of its bioactive chemicals. The created nanoparticles will be assessed based on particle size, zeta potential, encapsulation efficiency, and stability to ensure the development of an optimal and dependable nanoformulation with better physicochemical attributes
Disclaimer: Curated by HT Syndication.
